Rx only DESCRIPTION Tropicamide Ophthalmic Solution , USP is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths .
The active ingredient is represented by the following chemical structure : [ MULTIMEDIA ] Chemical name : Benzeneacetamide , N - ethyl - α - ( hydroxymethyl ) - N - ( 4 - pyridinylmethyl ) - Each mL contains : ACTIVE : Tropicamide 5 mg ( 0 . 5 % ) or 10 mg ( 1 % ) ; INACTIVES : Boric Acid , Hydrochloric Acid , Edetate Disodium Dihydrate , Purified Water .
Sodium Hydroxide and / or Hydrochloric Acid ( to adjust pH ) pH range 4 . 0 - 5 . 8 .
PRESERVATIVE ADDED : Benzalkonium Chloride 0 . 01 % .
[ MULTIMEDIA ] CLINICAL PHARMACOLOGY This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation , dilating the pupil [ mydriasis ] .
The stronger preparation ( 1 % ) also paralyzes accommodation .
This preparation acts in 15 - 30 minutes , and the duration of activity is approximately 3 - 8 hours .
Complete recovery from mydriasis in some individuals may require 24 hours .
The weaker strength ( 0 . 5 % ) may be useful in producing mydriasis with only slight cycloplegia .
Heavily pigmented irides may require more doses than lightly pigmented irides .
INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures .
CONTRAINDICATIONS Contraindicated in persons showing hypersensitivity to any component of this preparation .
WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY .
NOT FOR INJECTION .
This preparation may cause CNS disturbances which may be dangerous in pediatric patients .
The possibility of psychotic reaction and behavioral disturbance due to hypersensitivity to anticholinergic drugs should be considered .
Mydriatics may produce a transient elevation of intraocular pressure .
Remove contact lenses before using .
PRECAUTIONS General The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption .
Information for Patients Do not touch dropper tip to any surface , as this may contaminate the solution .
Patients should be advised not to drive or engage in potentially hazardous activities while pupils are dilated .
Patients may experience sensitivity to light and should protect eyes in bright illumination during dilation .
Parents should be warned not to get this preparation in their child ’ s mouth and wash their own hands and the child ’ s hands following administration .
Drug Interactions Tropicamide may interfere with the antihypertensive action of carbachol , pilocarpine , or ophthalmic cholinesterase inhibitors .
Carcinogenesis , Mutagenesis , Impairment of Fertility There have been no long - term studies done using tropicamide in animals to evaluate carcinogenic potential .
Pregnancy Animal reproduction studies have not been conducted with tropicamide .
It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
Tropicamide should be given to a pregnant woman only if clearly needed .
Nursing Mothers It is not known whether this drug is excreted in human milk .
Because many drugs are excreted in human milk , caution should be exercised when tropicamide is administered to a nursing woman .
Pediatric Use Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients .
Psychotic reactions , behavioral disturbances , and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs ( see WARNINGS ) .
Keep this and all medications out of the reach of children .
Geriatric Use No overall differences in safety or effectiveness have been observed between elderly and younger patients .
ADVERSE REACTIONS Ocular Transient stinging , blurred vision , photophobia and superficial punctate keratitis have been reported with the use of tropicamide .
Increased intraocular pressure has been reported following the use of mydriatics .
Non - Ocular Dryness of the mouth , tachycardia , headache , allergic reactions , nausea , vomiting , pallor , central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide .
Psychotic reactions , behavioral disturbances , and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs .
To report SUSPECTED ADVERSE REACTIONS , contact Bausch & Lomb Incorporated at 1 - 800 - 321 - 4576 or FDA at 1 - 800 - FDA - 1088 or www . fda . gov / medwatch .
DOSAGE AND ADMINISTRATION For refraction , one or two drops of the 1 % solution in the eye ( s ) , repeated in five minutes .
If patient is not seen within 20 to 30 minutes , an additional drop may be instilled to prolong mydriatic effect .
For examination of fundus , one or two drops of the 0 . 5 % solution 15 or 20 minutes prior to examination .
Individuals with heavily pigmented irides may require higher strength or more doses .
Mydriasis will reverse spontaneously with time , typically in 4 to 8 hours .
However , in some cases , complete recovery may take up to 24 hours .
HOW SUPPLIED Tropicamide Ophthalmic Solution , USP 1 % is supplied in a plastic bottle with a red cap and a controlled drop tip in the following sizes : NDC 24208 - 585 - 59 : 2 mL in a 7 . 5 mL bottle NDC 24208 - 585 - 64 : 15 mL in a 15 mL bottle Tropicamide Ophthalmic Solution , USP 0 . 5 % is supplied in a plastic bottle with a red cap and a controlled drop tip in the following sizes : NDC 24208 - 590 - 64 : 15 mL in a 15 mL bottle Storage : Store at 20 ° to 25 ° C ( 68 ° to 77 ° F ) ; excursions permitted between 15 ° to 30 ° C ( 59 ° to 86 ° F ) [ see USP Controlled Room Temperature ] .
Keep container tightly closed .
DO NOT USE IF IMPRINTED “ Protective Seal ” WITH YELLOW [ MULTIMEDIA ] IS NOT INTACT .
Keep out of reach of children .
Distributed by : Bausch + Lomb , a division of Bausch Health US , LLC Bridgewater , NJ 08807 USA Manufactured by : Bausch & Lomb Incorporated Tampa , FL 33637 USA © 2019 Bausch & Lomb Incorporated or its affiliates Revised : July 2019 9115806 ( Folded ) 9115906 ( Flat ) [ MULTIMEDIA ] PACKAGE / LABEL PRINCIPAL DISPLAY PANEL ( Mexico ) - 0 . 5 [ MULTIMEDIA ] NDC 24208 - 590 - 64 Tropicamide Ophthalmic Solution , USP 0 . 5 % Sterile FOR TOPICAL OPHTHALMIC USE ONLY Rx only 15 mL BAUSCH + LOMB [ MULTIMEDIA ] PACKAGE / LABEL PRINCIPAL DISPLAY PANEL Japan – 0 . 5 [ MULTIMEDIA ] NDC 24208 - 590 - 64 Tropicamide Ophthalmic Solution , USP 0 . 5 % Sterile FOR TOPICAL OPHTHALMIC USE ONLY Rx only 15 mL BAUSCH + LOMB [ MULTIMEDIA ] PACKAGE / LABEL PRINCIPAL DISPLAY PANEL Mexico 1 NDC 24208 - 585 - 64 Tropicamide Ophthalmic Solution , USP 1 % Sterile FOR TOPICAL OPHTHALMIC USE ONLY Rx only 15 mL BAUSCH + LOMB [ MULTIMEDIA ] [ MULTIMEDIA ] Package / Label Principal Display Panel Japan 1 NDC 24208 - 585 - 64 Tropicamide Ophthalmic Solution , USP 1 % Sterile FOR TOPICAL OPHTHALMIC USE ONLY Rx only 15 mL BAUSCH + LOMB [ MULTIMEDIA ] [ MULTIMEDIA ]
